News and Trends 28 Sep 2017
Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus
Abivax’s HIV cure candidate, ABX464, caused a significant drop in the viral reservoir over an extended period during a Phase IIa study. Abivax targets the immune system to cure viral diseases. The company has announced initial results from the first cohort of patients in its most recent Phase IIa trial testing its potential HIV cure, ABX464. Initial […]